Medtronic secures FDA approval for Altaviva device
Med-Tech Insights reports that Medtronic has received FDA approval for its Altaviva device, a minimally invasive implantable tibial neuromodulation (ITNM) therapy designed to treat urge urinary incontinence.
The device is implanted just above the ankle in a short procedure without the need for sedation or imaging, and delivers electrical impulses to the tibial nerve to restore communication between the bladder and brain. It features a battery lifespan of up to 15 years with only intermittent charging required, and is also MRI compatible.
This approval marks a significant step forward in MedTech, addressing a large and underserved market while providing patients with a simpler, long-lasting therapy option that reduces the burden of current treatments.
🔗 Read the full article on Med-Tech Insights: Medtronic secures FDA approval for Altaviva device
Credit for images and content: Med-Tech Insights
____________________________________________________________________________________________________________________________________________________________________________________________________
Cure Talent is a recruitment agency dedicated to the medical technology industry. Whether you are looking for a new role in the medical device sector or you’re an innovative medical device, digital health, or biotech company looking for staff, get in touch with the team today and explore how Cure Talent can help!